Hypershell raises an additional $50M in its $120M Series B round as consumer exoskeletons move beyond niche markets.

      Ant Group and Meituan Dragonball co-led a $50 million Series B+ round, with Sofina and Granite Asia also contributing. This increases the total Series B funding to $120 million, valuing the company at nearly $400 million post-money, just prior to Wednesday's global X-Series launch.

      Hypershell, a consumer exoskeleton firm based in Shanghai, has secured $50 million in a Series B+ round co-led by Ant Group and Meituan Dragonball (referred to as DragonBall Capital in the announcement), with participation from Sofina and Granite Asia. Cygnus Equity acted as the exclusive financial advisor.

      This funding represents the second tranche of the Series B, bringing the company's total raised amount to $120 million, aligning with a nearly $400 million post-money valuation, as confirmed by Yicai Global.

      The unique aspect of this round lies in its timing. According to Hypershell's disclosures, the broader B series was completed within a twelve-month timeframe: $70 million was raised in pre-B and B rounds in November 2024, led by Luminous Ventures and 5Y Capital, followed by the current $50 million Series B+.

      This sequence suggests that Ant Group and Meituan Dragonball invested at a pivotal moment when Hypershell transitioned from demonstrating product-market fit to proving its volume-scalability.

      The Hypershell X series is described by the company as the first consumer exoskeleton to rank first on Amazon in sales volume and market share across the US and Europe.

      The narrative behind this financing has been evident since 2023, when Hypershell launched its first consumer-grade exoskeleton Kickstarter campaign and received $1.23 million in pledges from 2,638 backers.

      The initial device adapted medical and industrial exoskeleton technology into a sub-2kg wearable aimed at hikers, travelers, athletes, and users needing mobility assistance.

      Various independent reviewers, including Fast Company’s gear desk, put the product through everyday consumer scenarios, yielding results consistent with the company's claims of a 30% reduction in physical exertion and a ~40% increase in leg strength.

      The new product, the Hypershell X Series, will launch globally at 13:00 BST on Wednesday, May 20. A key technical feature of the series is HyperIntuition, the company’s proprietary AI motion-control algorithm, which moves beyond predefined gait patterns into a closed-loop system for perception, recognition, prediction, and planning to interpret user intent in real-time.

      Additionally, this series is the first end-to-end consumer exoskeleton to be verified by TÜV Rheinland, which Hypershell presents as a signal of regulatory quality as the category expands into mainstream sales channels.

      Founded in 2021 by Kelvin Sun, the engineer behind hardware venture Lattepanda, Hypershell has a team divided between Beijing and Shenzhen, comprising around 100 employees. “Hypershell started with a simple idea: help people go farther,” said Sun in the announcement, noting the company’s reach into over 70 countries since its inception.

      The mix of strategic investors will influence future developments. Ant Group serves as the consumer-data-and-payment arm of Alibaba’s ecosystem, while Meituan Dragonball is the early-stage venture division of the consumer-services superapp Meituan. Both investors offer substantial distribution potential, with Ant’s Alipay network and Meituan’s logistics and service capabilities providing Hypershell with unexpected opportunities to penetrate the Chinese consumer market—a challenge that hardware-led brands typically face. Sofina and Granite Asia contribute continuity from the Western retail successes the company has already achieved.

      The competitive landscape includes a broader push for robotics in China, which has accelerated through 2026. This week, Barclays estimated that humanoid robots could counteract up to 60% of a projected decline in China's 37-million-worker labor force by 2035.

      Hypershell inhabits a different category from the humanoid robotics race: Unitree’s GD01 and its $7 billion IPO filing represent a formal comparable effort on the bipedal-humanoid side, while consumer exoskeletons focus on enhancing human capabilities rather than replacing them. These two product categories target different budget allocations but may attract overlapping investor interests.

      The press release does not address the ongoing question surrounding customer satisfaction versus supply in the larger Chinese consumer robotics market.

      Independent surveys currently indicate that buyer satisfaction among humanoid technology is merely 23% across more than 150 active manufacturers. Hypershell’s claim of leading sales on Amazon could serve as an encouraging indicator against this trend, but the launch of the New X Series on Wednesday will be the first instance where the company has operated with both the new funding and strategic distribution partnerships. The next two quarters will reveal whether Hypershell can successfully scale its launch.